Vergleich

Inhibitors & Compound Libraries

609594 Artikel

pro Seite

Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge Preis
YUM70 Inhibitors Other IC DCC-DC46184-1g

DCChemicals
1 g Anmelden
Vergleichen
11R-­VIVIT Inhibitors Other 11R-VIVIT is a potent NFAT inhibitor. 11R-VIVIT inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). 11R-VIVIT also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. 11R-VIVIT improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; en DCC-DC45087-10mg

DCChemicals
10 mg Anmelden
Vergleichen
11R-­VIVIT Inhibitors Other 11R-VIVIT is a potent NFAT inhibitor. 11R-VIVIT inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). 11R-VIVIT also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. 11R-VIVIT improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; en DCC-DC45087-25mg

DCChemicals
25 mg Anmelden
Vergleichen
11R-­VIVIT Inhibitors Other 11R-VIVIT is a potent NFAT inhibitor. 11R-VIVIT inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). 11R-VIVIT also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. 11R-VIVIT improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; en DCC-DC45087-100mg

DCChemicals
100 mg Anmelden
Vergleichen
DUN41875 Inhibitors Other DCC-DC45585-100mg

DCChemicals
100 mg Anmelden
Vergleichen
DUN41875 Inhibitors Other DCC-DC45585-250mg

DCChemicals
250 mg Anmelden
Vergleichen
DUN41875 Inhibitors Other DCC-DC45585-1g

DCChemicals
1 g Anmelden
Vergleichen
CDC 5-­LO inhibitor Inhibitors Other DCC-DC44939-100mg

DCChemicals
100 mg Anmelden
Vergleichen
CDC 5-­LO inhibitor Inhibitors Other DCC-DC44939-250mg

DCChemicals
250 mg Anmelden
Vergleichen
CDC 5-­LO inhibitor Inhibitors Other DCC-DC44939-1g

DCChemicals
1 g Anmelden
Vergleichen
Y-­27632 Inhibitors Other other DCC-DC45762-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Y-­27632 Inhibitors Other other DCC-DC45762-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Y-­27632 Inhibitors Other other DCC-DC45762-1g

DCChemicals
1 g Anmelden
Vergleichen
PFI-­90 Inhibitors Other other, IV DCC-DC45562-250mg

DCChemicals
250 mg Anmelden
Vergleichen
PFI-­90 Inhibitors Other other, IV DCC-DC45562-1g

DCChemicals
1 g Anmelden
Vergleichen
Trans-­4-­Phenyl-­3-­buten-­2-­one Inhibitors Other PLA DCC-DC45583-1g

DCChemicals
1 g Anmelden
Vergleichen
Tucatinib hemiethanolate Inhibitors Other IC DCC-DC45794-1g

DCChemicals
1 g Anmelden
Vergleichen
Vodobatinib Inhibitors Other IC DCC-DC44827-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Vodobatinib Inhibitors Other IC DCC-DC44827-250mg

DCChemicals
250 mg Anmelden
Vergleichen
EMAC10101d Inhibitors Other EMAC10101d is a potent and selective toward hCA II inhibitor, with a Ki of 8.1 nM. DCC-DC44166-1g

DCChemicals
1 g Anmelden
Vergleichen
AG-­636 Inhibitors Other AG-636 is an orally available inhibitor of dihydroorotate dehydrogenase (DHODH) with potential antineoplastic activity. DCC-DC45757-100mg

DCChemicals
100 mg Anmelden
Vergleichen
AG-­636 Inhibitors Other AG-636 is an orally available inhibitor of dihydroorotate dehydrogenase (DHODH) with potential antineoplastic activity. DCC-DC45757-250mg

DCChemicals
250 mg Anmelden
Vergleichen
AG-­636 Inhibitors Other AG-636 is an orally available inhibitor of dihydroorotate dehydrogenase (DHODH) with potential antineoplastic activity. DCC-DC45757-1g

DCChemicals
1 g Anmelden
Vergleichen
DTHIB Inhibitors Other DTHIB is a direct and selective heat shock factor 1 (HSF1) inhibitor with a Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB inhibits HSF1 cancer gene signature (HSF1 CaSig) and selectively stimulates degradation of nuclear HSF1. DCC-DC44513-100mg

DCChemicals
100 mg Anmelden
Vergleichen
DTHIB Inhibitors Other DTHIB is a direct and selective heat shock factor 1 (HSF1) inhibitor with a Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB inhibits HSF1 cancer gene signature (HSF1 CaSig) and selectively stimulates degradation of nuclear HSF1. DCC-DC44513-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Name Preis
YUM70 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 1 g
Lieferbar
11R-­VIVIT Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. 11R-VIVIT is a potent NFAT inhibitor. 11R-VIVIT inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). 11R-VIVIT also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. 11R-VIVIT improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; en
Host
ArtNr.
Menge 10 mg
Lieferbar
11R-­VIVIT Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. 11R-VIVIT is a potent NFAT inhibitor. 11R-VIVIT inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). 11R-VIVIT also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. 11R-VIVIT improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; en
Host
ArtNr.
Menge 25 mg
Lieferbar
11R-­VIVIT Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. 11R-VIVIT is a potent NFAT inhibitor. 11R-VIVIT inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). 11R-VIVIT also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. 11R-VIVIT improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; en
Host
ArtNr.
Menge 100 mg
Lieferbar
DUN41875 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
DUN41875 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
DUN41875 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
CDC 5-­LO inhibitor Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
CDC 5-­LO inhibitor Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
CDC 5-­LO inhibitor Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
Y-­27632 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 100 mg
Lieferbar
Y-­27632 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 250 mg
Lieferbar
Y-­27632 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 1 g
Lieferbar
PFI-­90 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. other, IV
Host
ArtNr.
Menge 250 mg
Lieferbar
PFI-­90 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. other, IV
Host
ArtNr.
Menge 1 g
Lieferbar
Trans-­4-­Phenyl-­3-­buten-­2-­one Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. PLA
Host
ArtNr.
Menge 1 g
Lieferbar
Tucatinib hemiethanolate Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 1 g
Lieferbar
Vodobatinib Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 100 mg
Lieferbar
Vodobatinib Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 250 mg
Lieferbar
EMAC10101d Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. EMAC10101d is a potent and selective toward hCA II inhibitor, with a Ki of 8.1 nM.
Host
ArtNr.
Menge 1 g
Lieferbar
AG-­636 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. AG-636 is an orally available inhibitor of dihydroorotate dehydrogenase (DHODH) with potential antineoplastic activity.
Host
ArtNr.
Menge 100 mg
Lieferbar
AG-­636 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. AG-636 is an orally available inhibitor of dihydroorotate dehydrogenase (DHODH) with potential antineoplastic activity.
Host
ArtNr.
Menge 250 mg
Lieferbar
AG-­636 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. AG-636 is an orally available inhibitor of dihydroorotate dehydrogenase (DHODH) with potential antineoplastic activity.
Host
ArtNr.
Menge 1 g
Lieferbar
DTHIB Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. DTHIB is a direct and selective heat shock factor 1 (HSF1) inhibitor with a Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB inhibits HSF1 cancer gene signature (HSF1 CaSig) and selectively stimulates degradation of nuclear HSF1.
Host
ArtNr.
Menge 100 mg
Lieferbar
DTHIB Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. DTHIB is a direct and selective heat shock factor 1 (HSF1) inhibitor with a Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB inhibits HSF1 cancer gene signature (HSF1 CaSig) and selectively stimulates degradation of nuclear HSF1.
Host
ArtNr.
Menge 250 mg
Lieferbar

609594 Artikel

pro Seite